Results 111 to 120 of about 18,311 (150)

Dimitrios Meletis. 2015. Graphetik. Form und Materialität von Schrift. Glückstadt: Verlag Werner Hülsbusch. 225 S.

Zeitschrift für Rezensionen zur Germanistischen Sprachwissenschaft, 2016
Gredig Andi
doaj   +1 more source

Exploring the Landscape of Immune Checkpoint Inhibitor-Induced Adverse Events Through Big Data Mining of Pan-Cancer Clinical Trials. [PDF]

Oncologist
Fadlullah MZH, Lin CN, Coleman S, Young A, Naqash AR, Hu-Lieskovan S, Tan AC.   +6 more
europepmc   +1 more source

Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients. [PDF]

Oncologist
Guerrero P, Albarrán V, González-Merino C, García de Quevedo C, Sotoca P, Chamorro J, Rosero DI, Barrill A, Alía V, Calvo JC, Moreno J, Pérez de Aguado P, Álvarez-Ballesteros P, San Román M, Serrano JJ, Soria A, Olmedo ME, Saavedra C, Cortés A, Gómez A, Lage Y, Ruiz Á, Ferreiro MR, Longo F, Guerra E, Martínez-Delfrade Í, Garrido P, Gajate P.   +27 more
europepmc   +1 more source

Evaluating Food and Drug Administration approved gastrointestinal cancer drugs: clinical benefit and trial endpoints over the past two decades. [PDF]

Oncologist
Jamal F, Sahvan O, Junior PLSU, Jones JC, Ou FS, Bekaii-Saab T, Sonbol MB.   +6 more
europepmc   +1 more source

First-line PD-1 +/- CTLA-4 blockade in patients with deficient mismatch repair and/or microsatellite instability-high metastatic colorectal cancer. [PDF]

Oncologist
Nasca V, Tinè G, Taieb J, Lonardi S, Boursi B, Margalit O, Salvatore L, Cohen R, Ros J, Ambrosini M, Zwart K, Roodhart J, Jayachandran P, Overman MJ, Elez ME, Cremolini C, Tougeron D, Koopman M, André T, Miceli R, Pietrantonio F.   +20 more
europepmc   +1 more source

PARP inhibitor therapy in patients with IDH1 mutated cholangiocarcinoma. [PDF]

Oncologist
Mohan A, Quingalahua E, Gunchick V, Paul S, Kumar-Sinha C, Crysler O, Zalupski MM, Sahai V.   +7 more
europepmc   +1 more source

Pancreatic cancer cell-intrinsic transglutaminase-2 promotes T cell suppression through microtubule-dependent secretion of immunosuppressive cytokines. [PDF]

J Immunother Cancer
Lahusen A, Minhöfer N, Lohse KA, Blechner C, Lindenmayer J, Eiseler T, Wellstein A, Kleger A, Seufferlein T, Windhorst S, Lin YN.   +10 more
europepmc   +1 more source

Vorwort

Zeitschrift für Rezensionen zur Germanistischen Sprachwissenschaft, 2015
doaj   +1 more source

Outcomes for recurrent or metastatic head and neck cancer by HPV status: a systematic review and meta-analysis. [PDF]

Oncologist
Park JC, Ye GH, Merkin R, Roberts T.
europepmc   +1 more source